Standout Papers

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. 2002 2026 2010 2018 507
  1. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (2002)
    John W. Park, Keelung Hong et al. PubMed

Immediate Impact

18 by Nobel laureates 16 from Science/Nature 115 standout
Sub-graph 1 of 15

Citing Papers

Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
2018 Standout
New Developments in Liposomal Drug Delivery
2015 Standout
55 intermediate papers

Works of Refaat Shalaby being referenced

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
2002 Standout
Tumor targeting using anti-her2 immunoliposomes
2001
and 5 more

Author Peers

Author Last Decade Papers Cites
Refaat Shalaby 1097 476 350 597 581 17 2.2k
Ying Men 941 85 370 1075 518 24 2.1k
Georges von Degenfeld 1204 88 193 389 333 40 2.6k
Samantha Stewart 505 259 434 320 144 46 1.5k
A. Meshorer 631 420 398 981 210 59 2.4k
Ed Luther 950 98 532 721 223 36 2.2k
Uma Prabhakar 1177 204 641 799 742 41 3.1k
Joseph G. Altin 1087 168 234 739 135 57 2.0k
Heather H. Gustafson 878 78 314 645 536 13 2.0k
Pascal Bailon 948 583 282 598 162 41 2.5k
Jerome Connor 1587 86 138 511 414 46 3.1k

All Works

Loading papers...

Rankless by CCL
2026